May 17 2023 Kelonia Therapeutics Presents Research Highlighting Potential of iGPS™ in vivo Gene Therapy to Bring Safe, Effective CAR T Therapies to Common Medical Practice for Treatment of All Multiple Myeloma Patients Read More
May 2 2023 Kelonia Therapeutics Announces Upcoming Oral Presentation of Preclinical Data with First Details of iGPS™ Technology at ASGCT Annual Meeting Read More
Apr 28 2022 Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Targeted Genetic Medicines Read More
Jul 7 2023 Myeloma Research News Gene therapy targeting T-cells shows promise in myeloma animal models Read More
May 17 2023 GEN Edge ASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T Cells Read More
Jan 26 2023 MedCity News As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing Read More
Apr 28 2022 Endpoints Gene therapy outfit emerges from stealth with big ambitions. First stop — CAR-T Read More
